Pandey Kushagra, Mishra Sandeep, Garg Kanwaljeet, Garg Ajay, Singh Manmohan, Kale Shashank Sharad
Department of Neurosurgery, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Department of Neuroimaging & Interventional Neuroradiology, All India Institute of Medical Sciences, New Delhi, India.
J Neurooncol. 2025 Aug;174(1):77-84. doi: 10.1007/s11060-025-05034-9. Epub 2025 Apr 9.
Tectal plate gliomas are slow-growing brainstem tumors often causing obstructive hydrocephalus. This study evaluates radiological response patterns and clinical outcomes of Gamma Knife radiosurgery (GKRS), a minimally invasive alternative for tumor control with lower risks than surgery.
A retrospective analysis was conducted on 10 patients treated with GKRS for tectal plate gliomas between January 2014 and November 2023 at a tertiary Gamma Knife Centre. Inclusion criteria required a minimum follow-up of one year with radiological assessment. Tumor volume, dose parameters, radiological responses, and clinical outcomes were documented.
The cohort comprised six females and four males, with a median age of 13 years (range: 2-31 years). Hydrocephalus was managed with endoscopic third ventriculostomy (50%) or ventriculoperitoneal shunting (40%). Histopathological confirmation, available in 40% of cases, revealed WHO Grade 2 diffuse astrocytoma. The median tumor volume was 2.18 cc, and a marginal dose of 12 Gy was delivered at a 50% isodose line. Radiological follow-up (median: 24 months) demonstrated a gradual reduction in tumor size in 90% of cases, with a median volume reduction of 56.7%. One patient exhibited pseudoprogression, and no cases of cystic degeneration or sustained tumor growth were observed. Clinically, 80% of patients reported symptomatic improvement, while 20% remained stable. Minor adverse effects, primarily headaches, were noted in four patients.
GKRS is a safe, effective treatment for tectal plate gliomas, offering significant tumor control with minimal complications. It primarily results in gradual tumor shrinkage, making it a viable alternative when surgery is not feasible.
顶盖板胶质瘤是生长缓慢的脑干肿瘤,常导致梗阻性脑积水。本研究评估伽玛刀放射外科治疗(GKRS)的放射学反应模式和临床结果,这是一种微创的肿瘤控制方法,风险低于手术。
对2014年1月至2023年11月在一家三级伽玛刀中心接受GKRS治疗的10例顶盖板胶质瘤患者进行回顾性分析。纳入标准要求至少随访一年并进行放射学评估。记录肿瘤体积、剂量参数、放射学反应和临床结果。
该队列包括6名女性和4名男性,中位年龄为13岁(范围:2 - 31岁)。脑积水通过内镜下第三脑室造瘘术(50%)或脑室腹腔分流术(40%)进行处理。40%的病例有组织病理学确诊,显示为世界卫生组织2级弥漫性星形细胞瘤。中位肿瘤体积为2.18立方厘米,在50%等剂量线处给予12 Gy的边缘剂量。放射学随访(中位:24个月)显示90%的病例肿瘤大小逐渐减小,中位体积减小56.7%。1例患者出现假性进展,未观察到囊性变或肿瘤持续生长的病例。临床上,80%的患者报告症状改善,20%保持稳定。4例患者出现轻微不良反应,主要为头痛。
GKRS是治疗顶盖板胶质瘤的一种安全、有效的方法,能在并发症极少的情况下实现显著的肿瘤控制。它主要导致肿瘤逐渐缩小,在手术不可行时是一种可行的替代方法。